Incannex Healthcare Inc. financial data

Symbol
IXHL on Nasdaq
Location
Norwest Nsw
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 570% % 72%
Debt-to-equity 28% % -35%
Return On Equity -194% % -6.4%
Return On Assets -151% % -19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 347,705,507 shares 1871%
Common Stock, Shares, Outstanding 347,705,507 shares 1871%
Entity Public Float $29,100,000 USD -55%
Common Stock, Value, Issued $35,000 USD 1650%
Weighted Average Number of Shares Outstanding, Basic 310,309,659 shares 1659%
Weighted Average Number of Shares Outstanding, Diluted 310,309,659 shares 1659%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $12,000 USD
Research and Development Expense $8,971,000 USD -32%
General and Administrative Expense $15,370,000 USD -16%
Operating Income (Loss) $24,329,000 USD 23%
Nonoperating Income (Expense) $23,543,000 USD -384%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $47,872,000 USD -107%
Net Income (Loss) Attributable to Parent $47,872,000 USD -107%
Earnings Per Share, Basic -1 USD/shares 21%
Earnings Per Share, Diluted -1 USD/shares 21%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $73,280,000 USD 1920%
Assets, Current $78,295,000 USD 415%
Property, Plant and Equipment, Net $168,000 USD -61%
Operating Lease, Right-of-Use Asset $212,000 USD -48%
Assets $78,720,000 USD 391%
Employee-related Liabilities, Current $52,000 USD -87%
Accrued Liabilities, Current $154,000 USD -98%
Contract with Customer, Liability, Current $30,000 USD -49%
Liabilities, Current $1,648,000 USD -82%
Operating Lease, Liability, Noncurrent $64,000 USD -71%
Liabilities $1,712,000 USD -82%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,901,000 USD 3.1%
Retained Earnings (Accumulated Deficit) $163,963,000 USD -41%
Stockholders' Equity Attributable to Parent $77,008,000 USD 1068%
Liabilities and Equity $78,720,000 USD 391%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,163,000 USD -308%
Net Cash Provided by (Used in) Financing Activities $67,177,000 USD
Net Cash Provided by (Used in) Investing Activities $42,000 USD
Common Stock, Shares Authorized 800,000,000 shares 700%
Common Stock, Shares, Issued 347,705,507 shares 1871%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,231,000 USD 62%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $73,280,000 USD 1920%
Operating Lease, Liability $211,000 USD -49%
Depreciation $66,000,000 USD -0.28%
Payments to Acquire Property, Plant, and Equipment $2,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $47,780,000 USD -113%
Lessee, Operating Lease, Liability, to be Paid $227,000 USD -50%
Property, Plant and Equipment, Gross $503,000 USD -20%
Operating Lease, Liability, Current $146,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Two $32,000 USD -37%
Lessee, Operating Lease, Liability, to be Paid, Year One $48,000 USD -77%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $16,000 USD -66%
Lessee, Operating Lease, Liability, to be Paid, Year Three $32,000 USD -82%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $11,790,000 USD 51%
Lessee, Operating Lease, Liability, to be Paid, Year Four $38,000 USD
Additional Paid in Capital $243,837,000 USD 94%
Share-based Payment Arrangement, Expense $442,000 USD -95%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%